Studies focusing on other cancer entities also reveal an overexpression of SNAT1 in human tumors, such as breast cancer [14], colorectal cancer [16], HCC [17], gastric cancer [18], and osteosarcoma [13], indicating an oncogenetic role of SNAT1 in cancer. Here, SLC38A1 is linked to hepatocellular carcinoma.